Pharma Mar, S.A. (VIE:PHM)

Pharma Mar Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,422	1,389	738	1,158	1,033	1,313
Market Cap Growth	5.85%	88.09%	-36.23%	12.13%	-21.36%	66.27%
Enterprise Value	1,326	1,298	608	1,014	866	1,176
Last Close Price	81.15	75.65	40.59	63.01	-	-
PE Ratio	41.83	53.17	649.51	23.46	11.12	9.57
PS Ratio	7.93	7.94	4.67	5.90	4.49	4.87
PB Ratio	7.20	6.67	3.82	5.19	5.81	12.78
P/TBV Ratio	7.25	6.70	3.84	5.22	5.84	12.91
P/FCF Ratio	85.07	-	-	39.30	57.78	4.76
P/OCF Ratio	66.97	230.47	-	30.22	40.22	4.71
EV/Sales Ratio	7.40	7.42	3.84	5.17	3.77	4.36
EV/EBITDA Ratio	45.61	128.91	-	22.60	9.12	7.39
EV/EBIT Ratio	60.28	200.70	-	24.11	9.37	7.51
EV/FCF Ratio	79.31	-	-	34.42	48.46	4.26
Debt / Equity Ratio	0.26	0.25	0.23	0.19	0.28	0.55
Debt / EBITDA Ratio	1.73	4.19	48.68	0.91	0.51	0.35
Debt / FCF Ratio	3.01	-	-	1.45	2.76	0.21
Asset Turnover	0.53	0.51	0.43	0.52	0.66	1.19
Inventory Turnover	0.20	0.18	0.29	0.71	1.46	1.32
Quick Ratio	2.03	2.29	1.98	2.18	2.93	2.31
Current Ratio	2.73	3.03	2.63	2.83	3.42	2.59
Return on Equity (ROE)	17.91%	13.00%	0.55%	24.62%	66.18%	249.16%
Return on Assets (ROA)	4.08%	1.17%	-0.65%	6.91%	16.54%	43.04%
Return on Capital (ROIC)	5.69%	1.63%	-0.95%	10.67%	29.89%	77.41%
Return on Capital Employed (ROCE)	8.70%	2.40%	-1.60%	14.20%	32.80%	66.60%
Earnings Yield	2.39%	1.88%	0.15%	4.26%	8.99%	10.45%
FCF Yield	1.18%	-0.65%	-3.83%	2.54%	1.73%	21.01%
Dividend Yield	1.01%	1.06%	1.60%	1.03%	-	-
Payout Ratio	41.02%	43.71%	1028.06%	23.83%	11.71%	6.42%
Buyback Yield / Dilution	-	1.98%	0.81%	0.12%	1.31%	0.77%
Total Shareholder Return	1.01%	3.03%	2.42%	1.15%	1.31%	0.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.